sponsored Introducing Felpreva® – a breakthrough in parasite protection for cats

Parasite protection for cats can be confusing for pets AND owners – knowing which products to use when, and in what combination.

Felpreva® is a breakthrough, all-in-one treatment option that helps to simplify parasite protection for cats:

  • Treats and protects against fleas and ticks for 13 weeks – the longest duration of action compared to other feline endectocides
  • Treats ear mites and all major types of endoparasites in the UK – including tapeworm
  • Easy to apply spot-on formulation
  • Fewer applications – applied just four times per year – aiming to reduce the stress

Felpreva®’s innovative combination of active ingredients, including emodepside, praziquantel and the new bispyrazole class ectoparasiticide tigolaner, provides treatment against:

External parasites

  • FleasCtenocephalides felis
  • TicksIxodes ricinus and Ixodes holocyclus
  • Ear and eat mythsOtodectes cynotis and Notoedres cati

Internal parasites

  • Roundworm and HookwormToxocara cati, Toxascaris leonina and Ancylostoma tubaeforme
  • TapewormDipylidium caninum and Taenia taeniaeformis
  • LungwormAelurostrongylus abstrusus and Troglostrongylus brevior

Learn more about Felpreva®’s mode of action:

Responsible use of parasiticides

Responsible use of parasiticides includes a risk assessment to determine the needs of individual cats, based on lifestyle factors and local parasite risks.

The European Counsel Companion Animal Parasites (ESCCAP) are committed to raising awareness of parasite risks and proven control measures to protect companion animals against parasites. Their guidelines and recommendations provide sound advice for clinicians to support a benefit-risk-based approach to parasiticide prescription.

When considering fleas, ESCCAP acknowledges that fleas present a year-round risk to cats1, and it is commonplace in practice to ensure full annual protection. Worming frequency is dependent on several risk factors with ESCCAP stating that outdoor cats should be protected against roundworm and tapeworm at least four times a year2.

Felpreva®’s unique combination of ingredients provides three-month protection against fleas and ticks alongside convenient quarterly worming… all with just four applications per year.

Benefit/risk-based approach

There are many factors which could influence a prescription for parasiticides including:

  • The cat’s age
  • Whether they are pregnant or lactating
  • Are they allowed outdoors?
  • Do they live in a multi-pet household?
  • Are they fed raw meat?
  • Are they a prolific hunter?
  • Do they live with children under five years of age

To support this risk-based approach and the launch of Felpreva®, Vetoquinol have produced a simple parasite risk-assessment form for cat owners to complete before their consultation. The form can be accessed via the QR code displayed to pet owners on a waiting room poster. Pet owners can complete the simple assessment and share their answers with themselves, who can use this to prescribe the most appropriate treatment regimen for that pet.

For more information, contact your local Vetoquinol Territory Manager.

Helping to support compliance

With 43% of cat owners saying they feel guilty, stressedhours worried about giving medication to their cats and one in two find having to administer more than one product do it confusing3it is easy to see how compliance can be negatively impacted.

By providing a convenient, all-in-one solution, Felpreva® helps to support pet owner compliance with year-round parasite protection for cats.

Discover Felpreva®

Learn more about how Felpreva® could support your cat owners by visiting the website, or by speaking to your local Vetoquinol Territory Manager today.


Felpreva® contains tigolaner, emodepside and praziquantel (POM-V). See the datasheet at www.noahcompendium.co.uk. The SPC and further information is available from Vetoquinol UK. Advice should be sought from the medicine prescriber. Use medicines responsibly – see www.noah.co.uk.


Leave a Comment